Benefits of whole body vibration training in patients hospitalised for COPD exacerbations - a randomized clinical trial

Table 1 Baseline characteristics

Measured parameter	Control	WBV	p-value
Gender [M/F]	12/8	14/6	0.74
Age [years]	70.4 ± 10.1	66.4 ± 9.93	0.24
Height [cm]	170.3 ± 10.63	168.9 ± 9.28	0.5
Weight [kg]	75.15 ± 19.73	79.5 ± 23.48	0.7
BMI [kg/m ² ]	25.75 ± 6.42	27.88 ± 7.87	0.51
FEV ₁ [% pred.]	38.4 ± 17.82	32.71 ± 13.18	0.43
GOLD stages [I/II/III/IV)	1/4/7/7	0/1/11/8	0.3
Current Smokers [%]	26.23	30	1.00
Mean Packyears*	47,50 ± 35,94	39,64 ± 27,91	0.53
On ICS before study [%]	64.29	70.59	1.00
On OCS before study [%]	14.29	23.53	0.66
Antibiotics [yes/no]	8/12	11/9	0.53

Data are displayed as mean ± standard deviation. There were no statistical differences between both groups. Mann–Whitney-U test was used to compare ordinal variables, categorial variables (gender, GOLD stages and antibiotics) were tested using the Exact Fisher test. BMI: Body mass index; FEV1: Forced exspiratory volume in one second; ICS: inhaled corticosteroids; OCS: Oral corticosteroids.

ISSN: 1471-2466